LSL Pharma Group Inc (TSE:LSL) has released an update.
LSL Pharma Group Inc has successfully completed the first closing of its non-brokered private placement, securing $1.5 million. This initial funding will support the expansion of production capabilities and provide general working capital. The company’s President and CEO, Francois Roberge, emphasized the strong investor interest and the company’s ongoing growth following a recent acquisition.
For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.
